Drug Discovery Market Outlook 2025–2029: Emerging Opportunities and Key Drivers

Uncover key drivers, emerging technologies, and competitive movements shaping the drug discovery market from 2025–2034 with trusted insights from The Business Research Company

What Is The Present Size Of The Drug Discovery Market And What Value Is Projected For 2029?

The drug discovery market has experienced substantial growth in recent years. Its size is predicted to increase from $110.26 billion in 2024 to $124.11 billion in 2025, achieving a compound annual growth rate (CAGR) of 12.6%. This past growth can be attributed to various factors such as advancements in genomics and proteomics, the expanding prevalence of chronic diseases, and the emergence of biopharmaceuticals.

The drug discovery market is projected to experience substantial growth in the coming years, with its size expected to reach $217.01 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 15.0%. This expansion during the forecast period is primarily driven by the increasing adoption of precision medicine, a stronger focus on rare diseases, and the broader availability of personalized therapies. Key trends anticipated in this period include the development of collaborative drug discovery models, continued emphasis on rare diseases and orphan drugs, the integration of multi-omics data, the rapid uptake of organoids and 3D cell culture models, and ongoing advancements in virtual screening techniques.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7746&type=smp

What Factors Are Boosting The Drug Discovery Market?

Increased healthcare spending is anticipated to drive the drug discovery market. Countries worldwide dedicate a substantial share of their GDP to healthcare expenses, which include hospital care, physician and clinical services, dental services, various other health, residential, and personal care, home health care, nursing care facilities, continuing care retirement communities, and prescription drugs. Drug discovery represents a significant portion of health expenditure, as it is crucial for treating diseases and extending life, with an escalating demand for new drugs to address novel diseases. For instance, in October 2024, the Centers for Medicare and Medicaid Services, a US-based federal agency, reported that national health expenditure grew 4.1% to $4.5 trillion in 2022, or $13,493 per person. Projections for 2023–32 indicate that the average national health expenditure growth (5.6%) is expected to exceed average GDP growth (4.3%), leading to an increase in health spending as a share of GDP from 17.3 percent in 2022 to 19.7 percent in 2032. Therefore, the rise in healthcare expenditures is a key driver for the growth of the drug discovery market.

What Are The Core Segmentation Criteria In The Drug Discovery Market?

The drug discovery market covered in this report is segmented –

1) By Drug Type: Small Molecule, Large Molecule

2) By Process: Target Selection, Target Validation, Hit-To-Lead Identification, Lead Optimization, Candidate Validation

3) By Technology: High Throughput Screening, Spectroscopy, Combinatorial Chemistry, Biochips, Pharmacogenomics And Pharmacogenetics, Bioinformatics, Metabolomics, Nanotechnology, Other Technologies

4) By Therapeutic Area: Oncology, Neurology, Infectious And Immune System Diseases, Digestive System Diseases, Cardiovascular Diseases, Diabetes, Respiratory Disease, Other Therapeutic Areas

5) By End User: Pharmaceutical Companies, CROs, Other End-Users

Subsegments:

1) By Small Molecule: Synthetic Small Molecules, Natural Small Molecules, Targeted Small Molecule Drugs

2) By Large Molecule: Monoclonal Antibodies, Proteins And Peptides, Nucleic Acid-Based Therapies

Which Emerging Trends Are Reshaping The Drug Discovery Market Landscape?

Technological advancements represent a significant trend within the drug discovery market. Companies active in the drug discovery market are introducing various new technologies, including AI, imaging technology, and others, with the goal of reducing the time needed for drug discovery. Imaging technology enables the non-invasive visualization, characterization, and quantification of biological activities occurring inside organisms in response to medications. These methodologies, which leverage the strengths of either probes or the tissue itself, are vital for understanding diseases and developing new treatments. For instance, in May 2023, Google Cloud recently launched two novel AI-powered tools, the Target and Lead Identification Suite and the Multiomics Suite, to expedite drug discovery and precision medicine. These tools are engineered to assist biotech and pharmaceutical companies in advancing drug discovery and precision medicine. The Target and Lead Identification Suite aids in identifying the function of amino acids and proteins, while the Multiomics Suite accelerates the discovery and interpretation of genomic data, thereby supporting the design of precision treatments.

Which Players Are Shaping The Competitive Landscape Of The Drug DiscoveryXX Market?

Major companies operating in the drug discovery market include Pfizer Inc., Merck & Co. Inc., Novartis International AG, Thermo Fisher Scientific Inc., WuXi AppTec Group, GlaxoSmithKline plc, Eli Lilly and Company, Laboratory Corporation of America Holdings, Evotec SE, Eurofins Scientific SE, Agilent Technologies Inc., Sanofi S.A., Charles River Laboratories International Inc., Pharmaron Ltd., Viva Biotech Ltd., Albany Molecular Research Inc., Schrödinger Inc., BioDuro Ltd., Aptuit LLC, Selvita S.A., Sygnature Discovery Limited, Jubilant Biosys Limited, Gero Limited, Domainex Ltd., Verge Genomics lnc., Aqemia SAS, BenevolentAI Limited, EPIVAX INC., ProteinQure lnc., Synlogic Inc., ChemPartner Co. Ltd., WuXi Biologics lnc., Abzena plc, Lonza Group Ltd., Catalent lnc., Recursion Pharmaceuticals Inc.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/drug-discovery-global-market-report

What Regional Trends Are Shaping Growth In The Drug Discovery Market?

North America was the largest region in the drug discovery market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug discovery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=7746&type=smp

Browse Through More Reports Similar to the Global Drug Discovery Market 2025, By The Business Research Company

3D Cell Culture Technologies Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/3d-cell-culture-technologies-global-market-report

Cell Based Assays Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cell-based-assays-global-market-report

Laboratory Automation Systems Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/laboratory-automation-systems-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795